Michael Bianco
Internal Medicine · Wadsworth, OHNPI 1740212885
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,958 and has fallen 98.2% since, to $35 in 2025. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$463
- AbbVie$431
- Amgen$357
- Cook Medical LLC$340
- Lilly USA, LLC$325
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,515100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 57 | $1,023 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $463 |
| AbbVie(2 entities) | 30 | $431 |
| Amgen | 24 | $357 |
| Cook Medical LLC | 4 | $340 |
| Lilly USA, LLC | 27 | $325 |
| AstraZeneca | 20 | $320 |
| GSK | 16 | $295 |
| Boehringer Ingelheim | 13 | $275 |
| Astellas Pharma US Inc | 10 | $174 |
| Biohaven Pharmaceuticals, Inc. | 15 | $154 |
| Amarin Pharma, Inc. | 10 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $143 |
| Integra Lifesciences Corporation | 1 | $143 |
| Novartis | 8 | $109 |
| Pfizer | 8 | $104 |
| Johnson & Johnson | 6 | $79 |
| Ironshore Pharmaceuticals Inc. | 4 | $68 |
| Clarus Therapeutics Inc. | 4 | $60 |
| Endo Pharmaceuticals Inc. | 4 | $59 |
| Genentech USA, Inc. | 3 | $56 |
| Merck | 4 | $53 |
| Sunovion Pharmaceuticals Inc. | 3 | $38 |
| Bayer | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Biogen | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Mannkind Corporation | 1 | $18 |
| UCB, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zenith Spiral-Z$171
- INTEGRA$143
- Lunderquist$124
- Ozempic$124
- TRELEGY ELLIPTA$122
- Xultophy 100/3.6$121
- JARDIANCE$119
How this compares
$5,533 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Wadsworth
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.